<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR87">
 <label>87.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aurelio</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Scullino</surname>
    <given-names>CV</given-names>
   </name>
   <name>
    <surname>Pitman</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Sexton</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Oliver</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Davies</surname>
    <given-names>L</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>From sphingosine kinase to dihydroceramide desaturase: a structureâ€“activity relationship (SAR) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl) thiazol-2-yl) amino) phenol (SKI-II)</article-title>
  <source>J Medicinal Chem</source>
  <year>2016</year>
  <volume>59</volume>
  <fpage>965</fpage>
  <lpage>84</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01439</pub-id>
 </element-citation>
</ref>
